/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
19.55% to 16.17%. due to the price of natural rubber, which is the main raw material cost for production, was higher than the same period of the previous year. For the six-month period of 2017, the
same period of the previous year by 4.79 million Baht and 9.77 million Baht respectively, due to the high price of natural rubber, which is the main raw material cost for production. The Company's
a result, the revenue of the Company was affected by the amount of approximately 13.6 million baht. 3. The Company has a higher cost in the year 2017 compared to 2016 because of higher raw material
112.18 Million Baht (earning per share 0.17 Baht) respectively due to the reason of: The cost of goods sold has been increased compared with the same period of 2016 due to the major of raw material such as
sold has been increased compared with 2016 due to the major of raw material such as natural rubber, synthetic rubber, carbon black and energy price which increased are directly affected to the production
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
and services increased by 10.87% from last year due to the sharp increment of raw material prices during Quarter 2 to Quarter 3 especially in natural rubber, synthetic rubber and chemicals groups. The